{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T05:13:29Z","timestamp":1794287609472,"version":"4.9.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Greek Rheumatology Society and Professional Association of Rheumatologists"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>RA and primary SS carry increased atherosclerotic risk, while B-cell activating factor holds a vital role in disease pathogenesis and atherosclerosis. We aimed to compare subclinical atherosclerosis profiles between the two clinical entities and define whether BAFF genetic variants alter atherosclerotic risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>DNA from 166 RA, 148 primary SS patients and 200 healthy controls of similar age and sex distribution was subjected to PCR-based assay for the detection of five single nucleotide polymorphisms of the BAFF gene (rs1224141, rs12583006, rs9514828, rs1041569 and rs9514827). Genotype and haplotype frequencies were determined by SNPStats software and statistical analysis was performed by SPSS and Graphpad Software. Subclinical atherosclerosis was defined by the presence of carotid\/femoral plaque formation and arterial wall thickening.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Atherosclerotic plaque formation was more frequently detected in the RA vs primary SS group (80.7% vs 62.2%, P-value &amp;lt;0.001), along with higher rates of family CVD history, current steroid dose and serum inflammatory markers. The TT genotype of the rs1224141 variant was more prevalent in RA but not primary SS patients with plaque and arterial wall thickening vs their counterparts without. Regarding the rs1014569 variant, among RA patients the TT genotype increased the risk for plaque formation while in primary SS patients the AT genotype conferred increased risk. Haplotype GTTTT was protective in the RA cohort, while TATTT and TTCTT haplotypes increased susceptibility for arterial wall thickening in the primary SS cohort.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Increased inflammatory burden, higher steroid doses and distinct BAFF gene variations imply chronic inflammation and B-cell hyperactivity as key contributors for the augmented atherosclerotic risk among autoimmune patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac337","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T13:43:42Z","timestamp":1654955022000},"page":"958-968","source":"Crossref","is-referenced-by-count":10,"title":["Subclinical atherosclerosis profiles in rheumatoid arthritis and primary Sj\u00f6gren\u2019s syndrome: the impact of <i>BAFF<\/i> genetic variations"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9887-3277","authenticated-orcid":false,"given":"Nikolaos","family":"Kintrilis","sequence":"first","affiliation":[{"name":"Department of Physiology, School of Medicine, National and Kapodistrian University of Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotini","family":"Gravani","sequence":"additional","affiliation":[{"name":"Department of Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rapti","sequence":"additional","affiliation":[{"name":"Department of Physiology, School of Medicine, National and Kapodistrian University of Athens"},{"name":"Department of Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrto","family":"Papaioannou","sequence":"additional","affiliation":[{"name":"Department of Physiology, School of Medicine, National and Kapodistrian University of Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina-Maria","family":"Flessa","sequence":"additional","affiliation":[{"name":"Department of Physiology, School of Medicine, National and Kapodistrian University of Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianos","family":"Nezos","sequence":"additional","affiliation":[{"name":"Department of Physiology, School of Medicine, National and Kapodistrian University of Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Antypa","sequence":"additional","affiliation":[{"name":"Department of Radiology, G. Gennimatas General Hospital of Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Papadaki","sequence":"additional","affiliation":[{"name":"Department of Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u03a4heofanis","family":"Karageorgas","sequence":"additional","affiliation":[{"name":"Department of Physiology, School of Medicine, National and Kapodistrian University of Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haralampos M","family":"Moutsopoulos","sequence":"additional","affiliation":[{"name":"Academy of Athens, Chair Medical Sciences, Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clio P","family":"Mavragani","sequence":"additional","affiliation":[{"name":"Department of Physiology, School of Medicine, National and Kapodistrian University of Athens"},{"name":"Joint Academic Rheumatology Program, National and Kapodistrian University of Athens, School of Medicine , Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"key":"2023020117304362900_keac337-B1","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1002\/art.30542","article-title":"Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis","volume":"63","author":"Giles","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2023020117304362900_keac337-B2","doi-asserted-by":"crossref","first-page":"e0151245","DOI":"10.1371\/journal.pone.0151245","article-title":"Rheumatoid arthritis and incidence of twelve initial presentations of cardiovascular disease: a population record-linkage cohort study in England","volume":"11","author":"Pujades-Rodriguez","year":"2016","journal-title":"PLoS One"},{"key":"2023020117304362900_keac337-B3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/ard.2006.059980","article-title":"Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?","volume":"67","author":"Gonzalez","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2023020117304362900_keac337-B4","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","article-title":"Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis","volume":"107","author":"Solomon","year":"2003","journal-title":"Circulation"},{"key":"2023020117304362900_keac337-B5","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"Avina-Zubieta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2023020117304362900_keac337-B6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/0961203318801673","article-title":"Primary Sj\u00f6gren's syndrome","volume":"27","author":"Bowman","year":"2018","journal-title":"Lupus"},{"key":"2023020117304362900_keac337-B7","first-page":"113","article-title":"The prevalence and relevance of traditional cardiovascular risk factors in primary Sj\u00f6gren's syndrome","volume":"36(Suppl 112)","author":"Bartoloni","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2023020117304362900_keac337-B8","first-page":"447","article-title":"Association between primary Sjogren's syndrome, arterial stiffness, and subclinical atherosclerosis: a systematic review and meta-analysis","volume":"38","author":"Yong","year":"2019","journal-title":"ClinRheumatol"},{"key":"2023020117304362900_keac337-B9","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","article-title":"BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth","volume":"189","author":"Schneider","year":"1999","journal-title":"J Exp Med"},{"key":"2023020117304362900_keac337-B10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.smim.2006.04.006","article-title":"BAFF, APRIL and their receptors: structure, function and signaling","volume":"18","author":"Bossen","year":"2006","journal-title":"Semin Immunol"},{"key":"2023020117304362900_keac337-B11","first-page":"1256","article-title":"Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis","volume":"35","author":"Bosello","year":"2008","journal-title":"J Rheumatol"},{"key":"2023020117304362900_keac337-B12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41392-019-0051-z","article-title":"Therapeutic effects of a novel BAFF blocker on arthritis","volume":"4","author":"Zhou","year":"2019","journal-title":"Signal Transduct Target Ther"},{"key":"2023020117304362900_keac337-B13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11926-012-0258-2","article-title":"The rationale for BAFF inhibition in systemic lupus erythematosus","volume":"14","author":"Davidson","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"2023020117304362900_keac337-B14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3899\/jrheum.120886","article-title":"Efficacy and safety of belimumab in patients with rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled, dose-ranging Study","volume":"40","author":"Stohl","year":"2013","journal-title":"J Rheumatol"},{"key":"2023020117304362900_keac337-B15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1517\/14712598.2012.758248","article-title":"Belimumab\u2013an anti-BLyS human monoclonal antibody for rheumatoid arthritis","volume":"13","author":"Jin","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"2023020117304362900_keac337-B16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clim.2016.01.015","article-title":"Early BAFF receptor blockade mitigates murine Sj\u00f6gren's syndrome: concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction","volume":"164","author":"Sharma","year":"2016","journal-title":"Clin Immunol"},{"key":"2023020117304362900_keac337-B17","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/annrheumdis-2013-203991","article-title":"Efficacy and safety of belimumab in primary Sj\u00f6gren's syndrome: results of the BELISS open-label phase II study","volume":"74","author":"Mariette","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2023020117304362900_keac337-B18","first-page":"2249","article-title":"Efficacy and safety of belimumab given for 12 months in primary Sj\u00f6gren\u2019s syndrome: the BELISS open-label phase II study","volume":"54","author":"De Vita","year":"2015","journal-title":"Rheumatology"},{"key":"2023020117304362900_keac337-B19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jaut.2018.05.002","article-title":"B-cell activating factor and related genetic variants in lupus related atherosclerosis","volume":"92","author":"Theodorou","year":"2018","journal-title":"J Autoimmun"},{"key":"2023020117304362900_keac337-B20","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.gene.6363923","article-title":"Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis","volume":"3","author":"Kawasaki","year":"2002","journal-title":"Genes Immun"},{"key":"2023020117304362900_keac337-B21","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2023020117304362900_keac337-B22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren's Syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2023020117304362900_keac337-B23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"2023020117304362900_keac337-B24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.echo.2007.11.011","article-title":"Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine [published correction appears in J Am Soc Echocardiogr. 2008 Apr;21(4):376]","volume":"21","author":"Stein","year":"2008","journal-title":"J Am Soc Echocardiogr"},{"key":"2023020117304362900_keac337-B25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13075-015-0613-6","article-title":"Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren's syndrome: prevalence, clinical and laboratory associations","volume":"17","author":"Gravani","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2023020117304362900_keac337-B26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ame2.12065","article-title":"Protective effect of hydroxychloroquine on rheumatoid arthritis-associated atherosclerosis","volume":"2","author":"Shi","year":"2019","journal-title":"Animal Model Exp Med"},{"key":"2023020117304362900_keac337-B27","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/s41440-020-0441-1","article-title":"Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients","volume":"43","author":"Dalbeni","year":"2020","journal-title":"Hypertension Research"},{"key":"2023020117304362900_keac337-B28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13075-019-1975-y","article-title":"Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study","volume":"21","author":"Ruscitti","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2023020117304362900_keac337-B29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3899\/jrheum.100564","article-title":"Cardiovascular disease is related to hypertension in patients with rheumatoid arthritis: a greek cohort study","volume":"38","author":"Serelis","year":"2011","journal-title":"J Rheumatol"},{"key":"2023020117304362900_keac337-B30","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1161\/01.CIR.100.21.2124","article-title":"A tale of two diseases: atherosclerosis and rheumatoid arthritis","volume":"100","author":"Pasceri","year":"1999","journal-title":"Circulation"},{"key":"2023020117304362900_keac337-B31","doi-asserted-by":"crossref","first-page":"574817","DOI":"10.1155\/2012\/574817","article-title":"Genetic markers of cardiovascular disease in rheumatoid arthritis","volume":"2012","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2012","journal-title":"Mediators Inflamm"},{"key":"2023020117304362900_keac337-B32","doi-asserted-by":"crossref","first-page":"9534","DOI":"10.1038\/s41598-022-13265-3","article-title":"Osteoprotegerin and MTHFR gene variations in rheumatoid arthritis: association with disease susceptibility and markers of subclinical atherosclerosis","volume":"12","author":"Arida","year":"2022","journal-title":"Sci Rep"},{"key":"2023020117304362900_keac337-B33","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1002\/art.21475","article-title":"Precocious intima-media thickening in patients with primary Sj\u00f6gren's syndrome","volume":"52","author":"Vaudo","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2023020117304362900_keac337-B34","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1038\/s41598-018-19580-y","article-title":"Increased risk of coronary heart disease among patients with primary Sj\u00f6gren\u2019s syndrome: a nationwide population-based cohort study","volume":"8","author":"Wu","year":"2018","journal-title":"Sci Rep"},{"key":"2023020117304362900_keac337-B35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.55563\/clinexprheumatol\/xef8uz","article-title":"Traditional and disease-related non-computed variables affect algorithms for cardiovascular risk estimation in Sj\u00f6gren's syndrome and rheumatoid arthritis","volume":"39(Suppl 133)","author":"Cafaro","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"2023020117304362900_keac337-B36","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1172\/JCI8472","article-title":"Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity","volume":"105","author":"Shaw","year":"2000","journal-title":"J Clin Invest"},{"key":"2023020117304362900_keac337-B37","doi-asserted-by":"crossref","first-page":"39904","DOI":"10.1038\/srep39904","article-title":"IFN type I and II induce BAFF secretion from human decidual stromal cells","volume":"7","author":"Lundell","year":"2017","journal-title":"Scientific Reports"},{"key":"2023020117304362900_keac337-B38","doi-asserted-by":"crossref","first-page":"498703","DOI":"10.3389\/fimmu.2020.498703","article-title":"Interferon \u03b1 enhances B cell activation associated with FOXM1 induction: potential novel therapeutic strategy for targeting the plasmablasts of systemic lupus erythematosus","volume":"11","author":"Akita","year":"2020","journal-title":"Front Immunol"},{"key":"2023020117304362900_keac337-B39","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/ar1912","article-title":"B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sj\u00f6gren's syndrome","volume":"8","author":"Ittah","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"2023020117304362900_keac337-B40","first-page":"185","article-title":"Type I interferon signature in Sj\u00f6gren's syndrome: pathophysiological and clinical implications","volume":"37(Suppl 118(3))","author":"Marketos","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2023020117304362900_keac337-B41","doi-asserted-by":"crossref","first-page":"581385","DOI":"10.3389\/fimmu.2020.581385","article-title":"IFN-I mediates dysfunction of endothelial progenitor cells in atherosclerosis of systemic lupus erythematosus","volume":"11","author":"Ding","year":"2020","journal-title":"Front Immunol"},{"key":"2023020117304362900_keac337-B42","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1182\/blood-2007-05-089086","article-title":"Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis","volume":"110","author":"Denny","year":"2007","journal-title":"Blood"},{"key":"2023020117304362900_keac337-B43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/1744666X.2019.1571411","article-title":"B cells and atherosclerosis in systemic lupus erythematosus","volume":"15","author":"Koulouri","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"2023020117304362900_keac337-B44","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/CIRCRESAHA.111.263186","article-title":"Lymphocytes and the adventitial immune response in atherosclerosis","volume":"110","author":"Campbell","year":"2012","journal-title":"Circ Res"},{"key":"2023020117304362900_keac337-B45","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/ATVBAHA.114.303569","article-title":"Targeting B cells in atherosclerosis: closing the gap from bench to bedside","volume":"35","author":"Tsiantoulas","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023020117304362900_keac337-B46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14728222.2020.1708325","article-title":"Evolving BAFF targeted therapies for preventing acute myocardial infarctions and ischemic strokes","volume":"24","author":"Kyaw","year":"2020","journal-title":"Expert Opin Ther Targets"},{"key":"2023020117304362900_keac337-B47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12872-020-01775-9","article-title":"Are activated B cells involved in the process of myocardial fibrosis after acute myocardial infarction? An in vivo experiment","volume":"21","author":"Mo","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"2023020117304362900_keac337-B48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/art.41485","article-title":"Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus","volume":"73","author":"Saidoune","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2023020117304362900_keac337-B49","doi-asserted-by":"crossref","first-page":"e29371","DOI":"10.1371\/journal.pone.0029371","article-title":"Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation","volume":"7","author":"Kyaw","year":"2012","journal-title":"PLoS One"},{"key":"2023020117304362900_keac337-B50","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.117.032790","article-title":"B Cell-activating factor neutralization aggravates atherosclerosis","volume":"138","author":"Tsiantoulas","year":"2018","journal-title":"Circulation"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac337\/44244574\/keac337.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/2\/958\/49031549\/keac337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/2\/958\/49031549\/keac337.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:41:05Z","timestamp":1675298465000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/2\/958\/6605896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,11]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,6,11]]},"published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac337","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2022,6,11]]}}}